Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ZTA-261
Cat. No.:
OB0425LY-236
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
ZTA-261 is a potent and low toxic thyroid hormone receptor β subtype (THR-β) agonist that reduces body weight.
Synonyms:
3049368-51-3; ZTA-261; ZTA261; ZTA261
CAS No.:
3049368-51-3
Formula:
C21H14F6O3
Formula Weight:
428.32
Specification
Target:
Thyroid hormone receptor
Pathway:
Vitamin D related/Nuclear receptor
Storage:
Storage at -20°C.
Applications:
ZTA-261 can be used in studies of lipid metabolism and obesity.
